Dr. Wonkyu Pak, MD

Dr. Pak practices at Los Angeles Ambulatory Surgery Center LLC in Los Angeles, California.

Dr. Pak's NPI, 1376542894, was assigned on July 18, 2005. Dr. Pak graduated from Vagelos College of Physicians and Surgeons in 1985. Dr. Pak holds California license G59023.

Dr. Pak's primary practice is Los Angeles Ambulatory Surgery Center LLC, at 266 S Harvard Blvd, Los Angeles, CA 90004 in Los Angeles County. The practice phone is (213) 387-9000.

Dr. Pak's primary practice is Los Angeles Ambulatory Surgery Center LLC in Los Angeles, California. Dmand AI also links Dr. Pak to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pak practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Pak's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Pak is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pak's licenses on file in 3 states: California, Missouri and Kansas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Pak treats.

CMS data shows 1,717 Medicare services from Dr. Pak across 15 procedure codes in 2024, for 441 Medicare patients. Medicare paid $131,845 for them.

CMS counts 441 Medicare patients who saw Dr. Pak in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 77% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pak's median patient age at 71, with 61% women.

In 2024, Dr. Pak wrote 9,475 Medicare Part D claims for 1,296 patients. 55% of them were for generic drugs. CMS names the drug for 9,400 of them, across 39 drugs with 11 or more claims each, at $1,733,462 in total drug cost. In 2023, CMS named 11,476 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Pak for performance year 2024, reported as part of a group. Dr. Pak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 66 procedures of cataract surgery by Dr. Pak, more than 68% of the clinicians it reports for that procedure.

CMS Open Payments shows 401 general payments to Dr. Pak from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Allergan Inc. paid the most, $2,033.

Dr. Pak graduated from Vagelos College of Physicians and Surgeons in 1985.

Dr. Pak is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.